Dr. Gitana Bradauskaite, MD

Dr. Bradauskaite practices at Jefferson Einstein Philadelphia Hospital in Philadelphia, Pennsylvania, part of Thomas Jefferson University.

Dr. Bradauskaite's NPI, 1902951304, was assigned on January 24, 2007. Dr. Bradauskaite holds Pennsylvania license MD442152.

Dr. Bradauskaite's primary practice is Jefferson Einstein Philadelphia Hospital, at 5501 Old York Road, Philadelphia, PA 19141 in Philadelphia County. The practice phone is (215) 456-6090.

Dr. Bradauskaite's primary practice is Jefferson Einstein Philadelphia Hospital in Philadelphia, Pennsylvania, part of Thomas Jefferson University. The medical group on file is Einstein Gastroenterology Associates. Dmand AI also links Dr. Bradauskaite to 1 more dialysis center, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bradauskaite practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Bradauskaite's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dmand AI has Dr. Bradauskaite's licenses on file in 2 states: Pennsylvania and Maryland.

CMS data shows 449 Medicare services from Dr. Bradauskaite across 6 procedure codes in 2024, for 168 Medicare patients. Medicare paid $34,668 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 168 Medicare patients who saw Dr. Bradauskaite in 2024. The largest group is under 65, with 79 patients. 75% of them have chronic kidney disease, and 75% have diabetes. 54% are also on Medicaid. Their average risk score is 6.60, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bradauskaite's median patient age at 60, with 42% women.

In 2024, Dr. Bradauskaite wrote 8,685 Medicare Part D claims for 323 patients. 90% of them were for generic drugs. CMS names the drug for 8,407 of them, across 68 drugs with 11 or more claims each, at $563,273 in total drug cost. In 2023, CMS named 8,409 claims across 68 drugs.

Dr. Bradauskaite accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 5 papers to Dr. Bradauskaite, published from 2014 to 2022. The most frequent topics are Kidney Transplantation. Dr. Bradauskaite has published most often in Exp Clin Transplant. Dr. Bradauskaite's most frequent co-authors are Joline L. Chen, MD, Daranee Chewaproug, DO and Manoj Das, MD.

Dmand AI links Dr. Bradauskaite to 1 clinical trial. 1 is still active or recruiting.

CMS Open Payments shows 264 general payments to Dr. Bradauskaite from 36 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 73% of the total. Calliditas Therapeutics US Inc. paid the most, $2,518.